Investment objective & strategy
As of June 30, 2025 · prospectusObjective. Total return greater than that of its benchmark, the GMO Global Asset Allocation Index, an internally maintained index computed by GMO consisting of 65% MSCI ACWI and 35% Bloomberg U.S. Aggregate Index.
Strategy. The Fund is a fund of funds and invests primarily in shares of other series of GMO Trust, including the Equity Funds, the Fixed Income Funds, the Implementation Funds, and the Alternative Funds, and in GMO-managed exchange-traded funds (collectively, the underlying GMO Funds) (see Additional Information About the Funds Investment Strategies, Risks, and Expenses Asset Allocation Funds). GMO uses its quantitative multi-year forecasts of returns among asset classes, together with its assessment of the relative risks of asset classes, to determine the asset classes in which the Fund invests and how much the Fund invests in each asset class. An important component of those forecasts is GMOs expectation that valuations ultimately revert to their fundamental fair (or intrinsic) value over … The Fund is a fund of funds and invests primarily in shares of other series of GMO Trust, including the Equity Funds, the Fixed Income Funds, the Implementation Funds, and the Alternative Funds, and in GMO-managed exchange-traded funds (collectively, the underlying GMO Funds) (see Additional Information About the Funds Investment Strategies, Risks, and Expenses Asset Allocation Funds). GMO uses its quantitative multi-year forecasts of returns among asset classes, together with its assessment of the relative risks of asset classes, to determine the asset classes in which the Fund invests and how much the Fund invests in each asset class. An important component of those forecasts is GMOs expectation that valuations ultimately revert to their fundamental fair (or intrinsic) value over a complete market cycle. GMO changes the Funds asset class exposures in response to changes in GMOs investment outlook and its assessment of market valuations and may use redemptions or purchases of Fund shares to rebalance the Funds investments. Under normal circumstances, GMO intends to invest not more than 85% of the Funds net assets in the Equity Funds. The factors GMO considers and investment methods GMO uses can change over time. The Fund is permitted to invest in any asset class (e.g., U.S. equity, non-U.S. equity, emerging country equity, U.S. fixed income, non-U.S. fixed income, emerging country debt, and commodities), strategy (e.g., long/short and event-driven strategies), sector, country, or region and at times may have substantial exposure to a single asset class, sector, country, region, issuer, or currency and companies with similar market capitalizations. In addition, the Fund is not restricted in its exposure to any particular market and may invest in securities of companies of any market capitalization and, in the case of debt instruments, of any credit quality (including below investment grade securities, commonly referred to as high yield or junk bonds), maturity and duration. In seeking to achieve the Funds investment objective, GMO may invest a significant portion of the Funds net assets in cash and cash equivalents. In addition, the Fund may lend its portfolio securities. The Fund also may invest in money market funds unaffiliated with GMO and directly in the types of investments typically held by money market funds.
Top holdings
As of Feb. 28, 2026 · N-PORT| Security | Ticker | Value | % of fund |
|---|---|---|---|
| GMO Alternative Allocation Fund | — | $89.43M | 15.59% |
| GMO International Equity Fund | — | $87.70M | 15.28% |
| GMO Asset Allocation Bond Fund | — | $81.22M | 14.15% |
| GMO US Equity Fund | — | $43.60M | 7.60% |
| GMO International Opportunistic Value Fund | — | $41.44M | 7.22% |
| GMO US Opportunistic Value Fund | — | $39.73M | 6.92% |
| GMO-Usonian Japan Value Creation Fund | — | $37.23M | 6.49% |
| GMO Emerging Markets Fund | — | $36.06M | 6.28% |
| GMO Emerging Markets ex-China Fund | — | $18.91M | 3.29% |
| GMO Opportunistic Income Fund | — | $16.96M | 2.96% |
Portfolio moves
Nov 30, 2025 → Feb 28, 2026How many positions this fund opened, exited, grew, trimmed, or left unchanged between its two most recent N-PORT snapshots — net changes between point-in-time reports, not a trade log.
Similar funds
Funds whose portfolios most overlap this one, by weight| Fund | Overlap | Net exp. |
|---|---|---|
| GMO Strategic Opportunities Allocation Fund · GBATX | 89% | 0.84% |
| GMO Global Equity Allocation Fund · GMGEX, GAAUX, GMADX | 63% | 0.58% |
| GMO Global Developed Equity Allocation Fund · GWOAX | 56% | 0.53% |
Advisers
| Firm | Role |
|---|---|
| Grantham Mayo van Otterloo & Co LLC | Adviser |
Footnotes
- Expense ratio as of June 30, 2025, from the fund's prospectus.
- Net assets and holdings count as of February 28, 2026, from the fund's N-PORT filing.
- Total return for calendar year 2025, before tax and after fund expenses. Computed by compounding the twelve monthly total returns the fund reported in its SEC N-PORT filings for 2025 (the latest prospectus does not yet chart this year).
Machine-readable: JSON · Markdown. Programmatic access via the agent surface.